MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/2159-8290.cd-22-0561

Медицинская библиотека · Cancer discovery · 2023

An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Venturutti Leandro, Rivas Martin A, Pelzer Benedikt W, Flümann Ruth, Hansen Julia, Karagiannidis Ioannis, Xia Min, McNally Dylan R, Isshiki Yusuke, Lytle Andrew, Teater Matt, Chin Christopher R, Meydan Cem, Knittel Gero, Ricker Edd, Mason Christopher E, Ye Xiaofei, Pan-Hammarström Qiang, Steidl Christian, Scott David W, Reinhardt Hans Christian, Pernis Alessandra B, Béguelin Wendy, Melnick Ari M

Редакционная статьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

UNLABELLED: A third of patients with diffuse large B-cell lymphoma (DLBCL) present with extranodal dissemination, which is associated with inferior clinical outcomes. MYD88L265P is a hallmark extranodal DLBCL mutation that supports lymphoma proliferation. Yet extranodal lymphomagenesis and the role of MYD88L265P in transformation remain mostly unknown. Here, we show that B cells expressing Myd88L252P (MYD88L265P murine equivalent) activate, proliferate, and differentiate with minimal T-cell costimulation. Additionally, Myd88L252P skewed B cells toward memory fate. Unexpectedly, the transcriptional and phenotypic profiles of B cells expressing Myd88L252P, or other extranodal lymphoma founder mutations, resembled those of CD11c+T-BET+ aged/autoimmune memory B cells (AiBC). AiBC-like cells progressively accumulated in animals prone to develop lymphomas, and ablation of T-BET, the AiBC master regulator, stripped mouse and human mutant B cells of their competitive fitness. By identifying a phenotypically defined prospective lymphoma precursor population and its dependencies, our findings pave the way for the early detection of premalignant states and targeted prophylactic interventions in high-risk patients.

SIGNIFICANCE: Extranodal lymphomas feature a very poor prognosis. The identification of phenotypically distinguishable prospective precursor cells represents a milestone in the pursuit of earlier diagnosis, patient stratification, and prophylactic interventions. Conceptually, we found that extranodal lymphomas and autoimmune disorders harness overlapping pathogenic trajectories, suggesting these B-cell disorders develop and evolve within a spectrum. See related commentary by Leveille et al. (Blood Cancer Discov 2023;4:8-11). This article is highlighted in the In This Issue feature, p. 1.

Для цитирования: Venturutti Leandro, Rivas Martin A, Pelzer Benedikt W, Flümann Ruth, Hansen Julia, Karagiannidis Ioannis, Xia Min, McNally Dylan R, Isshiki Yusuke, Lytle Andrew, Teater Matt, Chin Christopher R, Meydan Cem, Knittel Gero, Ricker Edd, Mason Christopher E, Ye Xiaofei, Pan-Hammarström Qiang, Steidl Christian, Scott David W, Reinhardt Hans Christian, Pernis Alessandra B, Béguelin Wendy, Melnick Ari M. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.. Cancer discovery. 2023. DOI: 10.1158/2159-8290.cd-22-0561.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.